Report - ESMO 2015 Consensus on Advanced Colorectal Cancer · § RAS mutant: FOLFOXIRI ±bevacizumab or acytotoxic ... 5-FU/capecitabine or capecitabine plus bevacizumab induction therapyshould

Please pass captcha verification before submit form